Cerebrovascular Events in Older Patients With Patent Foramen Ovale: Current Status and Future Perspectives

키워드

참고문헌 (69)

1. Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
2. Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
3. Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale : the DEFENSE-PFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
4. Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
5. Kasner SE, "Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 384, pp.970~971 (2021)
6. Messé SR, "Practice advisory update summary : patent foramen ovale and secondary stroke prevention : report of the guideline subcommittee of the American Academy of Neurology", Neurology, 94, pp.876~885 (2020)
7. Pristipino C, "European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism", Eur Heart J, 40, pp.3182~3195 (2019)
8. Kleindorfer DO, "2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline from the American Heart Association", American Stroke Association, 2021, pp.52, e364~e467
9. Gladstone DJ, "Canadian stroke best practice recommendations : secondary prevention of stroke update 2020", Can J Neurol Sci, 49, pp.315~337 (2022)
10. Kavinsky CJ, "SCAI guidelines for the management of patent foramen ovale", J Soc Cardiovasc Angiogr Interv, 1, pp.100039~ (2022)
11. Ahmed N, "Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018", Eur Stroke J, 4, pp.307~317 (2019)
12. Handke M, "Patent foramen ovale and cryptogenic stroke in older patients", N Engl J Med, 357, pp.2262~2268 (2007)
13. Mazzucco S, "Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis", Lancet Neurol, 17, pp.609~617 (2018)
14. Thaler DE, "Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs", Neurology, 83, pp.221~226 (2014)
15. Tobe J, "Transcranial Doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale", Can J Cardiol, 32, pp.986~ (2016)
16. Homma S, "Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale", Stroke, 35, pp.2145~2149 (2004)
17. Scacciatella P, "Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients : a two-center registry study", Catheter Cardiovasc Interv, 87, pp.508~514 (2016)
18. Wintzer-Wehekind J, "Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism", Rev Esp Cardiol(Engl Ed), 73, pp.219~224 (2020)
19. Nachoski D, "Dual-center experiences with interventional closure of patent foramen ovale : a medium-term follow-up study comparing two patient groups aged under and over 60 years", Clin Cardiol, 44, pp.386~391 (2021)
20. Poli S, "Closure or medical therapy of patent foramen ovale in cryptogenic stroke : prospective case series", Neurol Res Pract, 3, pp.16~ (2021)
21. Alperi A, "Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events", Circ Cardiovasc Interv, 15, pp.e011652~ (2022)
22. Tsao CW, "Heart disease and stroke statistics—2022update : a report from the American Heart Association", Circulation, 145, pp.e153~e639 (2022)
23. Ding Q, "Global, regional, and national burden of ischemic stroke, 1990-2019", Neurology, 98, pp.e279~e290 (2022)
24. Ntaios G, "Embolic stroke of undetermined source : JACC review topic of the week", J Am Coll Cardiol, 75, pp.333~340 (2020)
25. Elgendy AY, "Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke", JAMA Neurol, 77, pp.878~886 (2020)
26. Hagen PT, "Incidence and size of patent foramen ovale during the first 10 decades of life : an autopsy study of 965 normal hearts", Mayo Clin Proc, 59, pp.17~20 (1984)
27. Koutroulou I, "Epidemiology of patent foramen ovale in general population and in stroke patients : a narrative review", Front Neurol, 11, pp.281~ (2020)
28. Mac Grory B, "Advances in the management of cardioembolic stroke associated with patent foramen ovale", BMJ, 376, pp.e063161~ (2022)
29. Alsheikh-Ali AA, "Patent foramen ovale in cryptogenic stroke : incidental or pathogenic?", Stroke, 40, pp.2349~2355 (2009)
30. Lechat P, "Prevalence of patent foramen ovale in patients with stroke", N Engl J Med, 318, pp.1148~1152 (1988)
31. Overell JR, "Interatrial septal abnormalities and stroke : a meta-analysis of case-control studies", Neurology, 55, pp.1172~1179 (2000)
32. Anderson RG, "Paradoxical embolism", Br Med J, 1, pp.836~ (1946)
33. Saver JL, "Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke : a topical review", Stroke, 49, pp.1541~1548 (2018)
34. Yan C, "Preliminary investigation of in situ thrombus within patent foramen ovale in patients with and without stroke", JAMA, 325, pp.2116~2118 (2021)
35. Nakayama R, "Identification of high-risk patent foramen ovale associated with cryptogenic stroke : development of a scoring system", J Am Soc Echocardiogr, 32, pp.811~816 (2019)
36. Lee JY, "Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale", Am J Cardiol, 106, pp.129~134 (2010)
37. Fukuoka T, "Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale", J Neurol, 259, pp.1051~1055 (2012)
38. Vizzari G, "Patent foramen ovale : anatomical complexity and longtunnel morphology related issues", Am J Cardiovasc Dis, 11, pp.316~329 (2021)
39. Turc G, "Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale", J Am Coll Cardiol, 75, pp.2312~2320 (2020)
40. Benvenuti F, "Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke", Neurol Sci, 43, pp.453~458 (2022)
41. Cai Q, "Eustachian valve, interatrial shunt, and paradoxical embolism", Echocardiography, 37, pp.939~944 (2020)
42. Mas JL, "Association of atrial septal aneurysm and shunt size with stroke recurrence and benefit from patent foramen ovale closure", JAMA Neurol, 79, pp.1175~1179 (2022)
43. Hołda MK, "Patent foramen ovale channel morphometric characteristics associated with cryptogenic stroke : the MorPFO score", J Am Soc Echocardiogr, 34, pp.1285~1293 (2021)
44. Garg A, "Recurrent stroke reduction with patent foramen ovale closure versus medical therapy based on patent foramen ovale characteristics : a meta-analysis of randomized controlled trials", Cardiology, 144, pp.40~49 (2019)
45. Kent DM, "An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke", Neurology, 81, pp.619~625 (2013)
46. Kent DM, "Risk of paradoxical embolism(RoPE)–estimated attributable fraction correlates with the benefit of patent foramen ovale closure : an analysis of 3 trials", Stroke, 51, pp.3119~3123 (2020)
47. Kent DM, "Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke", JAMA, 326, pp.2277~2286 (2021)
48. Abo-Salem E, "Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials", J Neurol, 265, pp.578~585 (2018)
49. Almekhlafi MA, "Recurrent cerebral ischemia in medically treated patent foramen ovale : a meta-analysis", Neurology, 73, pp.89~97 (2009)
50. Hou Y, "Potential embolic sources differ in patients with embolic stroke of undetermined source according to age : a 15-year study", Front Neurol, 13, pp.860827~ (2022)
51. Mazzucco S, "Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials : a population-based study and systematic review", JAMA Neurol, 77, pp.1279~1287 (2020)
52. Hanim Kwon, "Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial", 대한뇌졸중영문학회지, 23(2), pp.289~292 (2021), 대한뇌졸중학회[DOI]
53. Kniffin WD Jr, "The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly", Arch Intern Med, 154, pp.861~866 (1994)
54. Stein PD, "Venous thromboembolism according to age : the impact of an aging population", Arch Intern Med, 164, pp.2260~2265 (2004)
55. Scurr JH, "Frequency and prevention of symptomless deepvein thrombosis in long-haul flights : a randomised trial", Lancet, 357, pp.1485~1489 (2001)
56. Nicholls SC, "Venous thromboembolism : detection by duplex scanning", J Vasc Surg, 23, pp.511~516 (1996)
57. Zietz A, "Deep vein thrombosis and pulmonary embolism among patients with a cryptogenic stroke linked to patent foramen ovale—a review of the literature", Front Neurol, 11, pp.336~ (2020)
58. Henein M, "The normal impact of age and gender on right heart structure and function", Echocardiography, 31, pp.5~11 (2014)
59. Luu JM, "Normal sex and age-specific parameters in a multi-ethnic population : a cardiovascular magnetic resonance study of the Canadian alliance for healthy hearts and minds cohort", J Cardiovasc Magn Reson, 24, pp.2~ (2022)
60. Chen JZ, "Atrial fibrillation following patent foramen ovale closure : systematic review and meta-analysis of observational studies and clinical trials", Stroke, 52, pp.1653~1661 (2021)
61. Tsivgoulis G, "Prolonged cardiac monitoring and stroke recurrence : a meta-analysis", Neurology, 98, pp.e1942~e1952 (2022)
62. Chaisinanunkul N, "How often is occult atrial fibrillation in cryptogenic stroke causal vs. incidental? A meta-analysis", Front Neurol, 14, pp.1103664~ (2023)
63. Kiblawi FM, "Transcatheter closure of patent foramen ovale in older adults", Catheter Cardiovasc Interv, 68, pp.136~142 (2006)
64. "PFO closure, oral anticoagulants or antiplatelet therapy after PFO-associated stroke in patients aged 60 to 80 years (CLOSE-2)" (2022)[URL]
65. "Prospective registry of elderly ESUS with PFO (COACH_ESUS)" (2022)[URL]
66. "Evaluation of prevalence and clinical impact of atrial fibrillation in elderly patients with cryptogenic stroke and high-risk patent foramen ovale (DefenseElderly)" (2020)[URL]
67. "Secondary stroke prevention in patients with patent foramen ovale: international PFO consortium" (2017)[URL]
68. Furlan AJ, "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", N Engl J Med, 366, pp.991~999 (2012)
69. Meier B, "Percutaneous closure of patent foramen ovale in cryptogenic embolism", N Engl J Med, 368, pp.1083~1091 (2013)

관련 논문AI추천